BUSINESS
F&O manual | Some recovery is visible but traders suggest to wait for long addition
BUSINESS
Know your stock | Is there a glimmer of hope for SeQuent Scientific?
BUSINESS
F&O Manual: Write calls at higher strike prices for Nifty, analysts say
BUSINESS
Krsnaa Diagnostics shares soar on network expansion
BUSINESS
F&O Manual: Initiate bearish put spread on Bank Nifty as setup remains weak, say analysts
BUSINESS
Analyst Call Tracker: Why do analysts favour Titan even as investors lose interest in the stock?
BUSINESS
Analyst Call Tracker: Why Dr Reddy's acquisition of Maynes Pharma failed to cheer analysts?
BUSINESS
Analyst Call Tracker: Why three auto stocks are winning over analysts amid price volatility?
BUSINESS
SeQuent Scientific zooms 20% on terminating Tineta Pharma acquisition
BUSINESS
Navy Ramavat of Indira Securities predicts sustainable rebound for Nifty
BUSINESS
Trader's Mela 2023: Sentiment seen cautiously optimistic this week
BUSINESS
Bajaj Electricals shares gain on bagging order worth Rs 564 crore
BUSINESS
Adani Green's operating renewable portfolio reaches 8,024 MW; stock in upper circuit
BUSINESS
Contrarian calls | Profit-booking drags automobile firms but analysts bullish on sector
BUSINESS
Railway stocks surge on lowest bid for Vande Bharat trains
BUSINESS
ZEE breaks 6-day losing streak, surges 7%, as NSE issues fresh F&O contracts
BUSINESS
Small pharma cos curtailing investments in the US, says Jefferies
BUSINESS
Sanofi India shares clock biggest intraday gain in 7 months on robust bottomline
BUSINESS
Is network expansion the booster dose diagnostic firms need?
BUSINESS
ShareKhan has a 'neutral' stance on pharma companies; here's why
BUSINESS
SpiceJet shares inch higher ahead of Q3 earnings, board meet
BUSINESS
Price hikes are changing the game for diagnostic cos; here's how analysts see it
BUSINESS
HG Infra gains on winning Rs 466-crore RVNL project
BUSINESS
Easing margin pressures, uptick in US sales saving grace for pharma firms in Q3
